Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
$125.82
+1.65%today
MKT CAP
$10.0B
-1.0% · 1Y
Earnings History
-25.4%
+6.1%
-214.0%
-13.1%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$125.82
Low
$131.00
Analyst Mean
$155.20
High
$176.00
10 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E-43.7x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-77.0%
5y Revenue CAGR+258.3%
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership0.0%
Institutional Ownership79.2%
Short % of Float3.27%
Days to Cover2.4d
1 Week+9.9%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| TCG Crossover Management, LLC | institution | 8.97% | $0.87B | +0.00% | 2025-12-31 |
| UBS Group AG | institution | 5.58% | $0.54B | -0.84% | 2025-12-31 |
| Darwin Global Management, Ltd. | institution | 4.01% | $0.39B | +0.44% | 2025-12-31 |
| Morgan Stanley | institution | 3.98% | $0.39B | +114.32% | 2025-12-31 |
| Point72 Asset Management, L.P. | institution | 3.04% | $0.30B | -17.65% | 2025-12-31 |
| Vestal Point Capital, LP | institution | 2.40% | $0.23B | +90.00% | 2025-12-31 |
| Caligan Partners, LP | institution | 1.83% | $0.18B | +0.00% | 2025-12-31 |
| Paradigm Biocapital Advisors LP | institution | 1.79% | $0.17B | -9.38% | 2025-12-31 |
| FMR, LLC | institution | 1.72% | $0.17B | -4.54% | 2025-12-31 |
| Cormorant Asset Management, LP | institution | 1.70% | $0.17B | -30.77% | 2025-12-31 |
| LORD ABBETT SECURITIES TRUST-Lord Abbett Growth Leaders Fund | fund | 0.59% | $0.06B | +100.00% | 2026-01-31 |
| T. Rowe Price Health Sciences Fund, Inc. | fund | 0.49% | $0.05B | +31.41% | 2025-12-31 |
| iShares Trust-iShares Biotechnology ETF | fund | 0.46% | $0.05B | -6.66% | 2026-03-31 |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | fund | 0.43% | $0.04B | +1.87% | 2026-02-28 |
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | fund | 0.41% | $0.04B | -17.40% | 2025-12-31 |
| ALGER INSTITUTIONAL FUNDS-Alger Focus Equity Fund | fund | 0.41% | $0.04B | +4.27% | 2026-01-31 |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | fund | 0.38% | $0.04B | -24.37% | 2026-02-28 |
| ALGER FUNDS II-Alger Spectra Fund | fund | 0.35% | $0.03B | +8.58% | 2026-01-31 |
| HARBOR FUNDS-Harbor Small Cap Growth Fund | fund | 0.35% | $0.03B | +55.41% | 2026-01-31 |
| abrdn World Healthcare Fund | fund | 0.33% | $0.03B | -51.02% | 2025-12-31 |
| Ticker | Cap | Score | P/E | Fwd P/E | EV/EBITDA | ROE | Gross | D/E | Div |
|---|---|---|---|---|---|---|---|---|---|
| BMRN | $10.5B | 49 | 38.9 | 8.1 | 15.3 | 4.5% | 51% | 23.17 | 0.00% |
| CYTK | $9.3B | - | - | - | - | - | - | - | 0.00% |
| PRAX | $9.3B | 5 | - | - | - | - | - | - | 0.00% |
| ARWR | $11.0B | 12 | 49.5 | - | - | - | - | - | 0.00% |
| AXSM | $11.4B | 49 | - | 37.4 | - | -349.4% | 93% | 402.84 | 0.00% |
| IBRX | $8.7B | 5 | - | - | - | - | - | - | 0.00% |
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for ABVX.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.